InVitria Launches Animal-Origin Free Transferrin
Colorado-based InVitria, a division of the biopharmaceutical company Ventria Bioscience, has launched an animal-free recombinant transferrin for use in mammalian cell culture.
Colorado-based InVitria, a division of the biopharmaceutical company Ventria Bioscience, has launched an animal-free recombinant transferrin for use in mammalian cell culture.
The new cell culture supplement, called Optiferrin, which supports cell growth by regulating the amount of iron transported to the cell. Because iron is required for healthy cell culture performance, it is a critical component to reach optimal performance.
Optiferrin addresses the need for animal-free transferrin in many applications including stem cells, primary cells, hybridoma cells, and Chinese hamster ovary cells.
According to the company’s press release, Optiferrin has undergone extensive testing by beta customers, who formulated Optiferrin into their cell culture media and liked the results.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
